159 related articles for article (PubMed ID: 33416177)
1. TELO2 induced progression of colorectal cancer by binding with RICTOR through mTORC2.
Guo Z; Zhang X; Zhu H; Zhong N; Luo X; Zhang Y; Tu F; Zhong J; Wang X; He J; Huang L
Oncol Rep; 2021 Feb; 45(2):523-534. PubMed ID: 33416177
[TBL] [Abstract][Full Text] [Related]
2. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
3. Small nucleolar RNA host gene 1 promotes development and progression of colorectal cancer through negative regulation of miR-137.
Fu Y; Yin Y; Peng S; Yang G; Yu Y; Guo C; Qin Y; Zhang X; Xu W; Qin Y
Mol Carcinog; 2019 Nov; 58(11):2104-2117. PubMed ID: 31469189
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis.
Schmidt KM; Dietrich P; Hackl C; Guenzle J; Bronsert P; Wagner C; Fichtner-Feigl S; Schlitt HJ; Geissler EK; Hellerbrand C; Lang SA
Neoplasia; 2018 Dec; 20(12):1198-1208. PubMed ID: 30404068
[TBL] [Abstract][Full Text] [Related]
5. UBXN2A, a Ubiquitin-Like Protein, Alters Proteins in mTORC2 Pathway.
Reihe C
S D Med; 2022 Oct; 75(10):456-458. PubMed ID: 36889268
[TBL] [Abstract][Full Text] [Related]
6. Differential roles and activation of mammalian target of rapamycin complexes 1 and 2 during cell migration in prostate cancer cells.
Venugopal SV; Caggia S; Gambrell-Sanders D; Khan SA
Prostate; 2020 Apr; 80(5):412-423. PubMed ID: 31995655
[TBL] [Abstract][Full Text] [Related]
7. Expression of Raptor and Rictor and their relationships with angiogenesis in colorectal cancer.
Wen FF; Li XY; Li YY; He S; Xu XY; Liu YH; Liu L; Wu SH
Neoplasma; 2020 May; 67(3):501-508. PubMed ID: 32039630
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
[TBL] [Abstract][Full Text] [Related]
9. UBXN2A suppresses the Rictor-mTORC2 signaling pathway, an established tumorigenic pathway in human colorectal cancer.
Sane S; Srinivasan R; Potts RA; Eikanger M; Zagirova D; Freeling J; Reihe CA; Antony RM; Gupta BK; Lynch D; Bleeker J; Turaihi H; Pillatzki A; Zhou W; Luo X; Linnebacher M; Agany D; Zohim EG; Humphrey LE; Black AR; Rezvani K
Oncogene; 2023 May; 42(21):1763-1776. PubMed ID: 37037900
[TBL] [Abstract][Full Text] [Related]
10. Autophagy-related genes Raptor, Rictor, and Beclin1 expression and relationship with multidrug resistance in colorectal carcinoma.
Shuhua W; Chenbo S; Yangyang L; Xiangqian G; Shuang H; Tangyue L; Dong T
Hum Pathol; 2015 Nov; 46(11):1752-9. PubMed ID: 26363527
[TBL] [Abstract][Full Text] [Related]
11. mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.
Holmes B; Benavides-Serrato A; Freeman RS; Landon KA; Bashir T; Nishimura RN; Gera J
Oncogene; 2018 Feb; 37(6):732-743. PubMed ID: 29059166
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition.
Kim ST; Kim SY; Klempner SJ; Yoon J; Kim N; Ahn S; Bang H; Kim KM; Park W; Park SH; Park JO; Park YS; Lim HY; Lee SH; Park K; Kang WK; Lee J
Ann Oncol; 2017 Mar; 28(3):547-554. PubMed ID: 28028034
[TBL] [Abstract][Full Text] [Related]
13. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.
Gulhati P; Bowen KA; Liu J; Stevens PD; Rychahou PG; Chen M; Lee EY; Weiss HL; O'Connor KL; Gao T; Evers BM
Cancer Res; 2011 May; 71(9):3246-56. PubMed ID: 21430067
[TBL] [Abstract][Full Text] [Related]
14. mTORC2/Rictor is essential for coelomocyte endocytosis in Apostichopus japonicus.
Lv Z; Yue Z; Shao Y; Li C; Zhao X; Guo M
Dev Comp Immunol; 2021 May; 118():104000. PubMed ID: 33444645
[TBL] [Abstract][Full Text] [Related]
15. Targeted inhibition of mammalian target of rapamycin signaling inhibits tumorigenesis of colorectal cancer.
Gulhati P; Cai Q; Li J; Liu J; Rychahou PG; Qiu S; Lee EY; Silva SR; Bowen KA; Gao T; Evers BM
Clin Cancer Res; 2009 Dec; 15(23):7207-16. PubMed ID: 19934294
[TBL] [Abstract][Full Text] [Related]
16. Long non‑coding RNA SNHG20 promotes colorectal cancer cell proliferation, migration and invasion via miR‑495/STAT3 axis.
Wang Y; Fu J; Yang L; Liang Z
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179110
[TBL] [Abstract][Full Text] [Related]
17. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
[TBL] [Abstract][Full Text] [Related]
18. mTORC2 Assembly Is Regulated by USP9X-Mediated Deubiquitination of RICTOR.
Wrobel L; Siddiqi FH; Hill SM; Son SM; Karabiyik C; Kim H; Rubinsztein DC
Cell Rep; 2020 Dec; 33(13):108564. PubMed ID: 33378666
[TBL] [Abstract][Full Text] [Related]
19. Vimentin loss promotes cancer proliferation through up-regulating Rictor/AKT/β-catenin signaling pathway.
Ding Y; Lv C; Zhou Y; Zhang H; Zhao L; Xu Y; Fan X
Exp Cell Res; 2021 Aug; 405(1):112666. PubMed ID: 34052237
[TBL] [Abstract][Full Text] [Related]
20. PTH(1‑34) activates the migration and adhesion of BMSCs through the rictor/mTORC2 pathway.
Lv Z; Muheremu A; Bai X; Zou X; Lin T; Chen B
Int J Mol Med; 2020 Dec; 46(6):2089-2101. PubMed ID: 33125102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
